| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
5e-09 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-09 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |